ConductScience.org, home

Paper22706128

Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation.

Herreros MD and 5 others. Dis Colon Rectum, 2012. Cited by 211 papers, by iCite.

Cite this record

ConductScience Library. Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation. Papers, record 22706128. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22706128

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation.
PubMed
Journal
Dis Colon Rectum
PubMed
Year
2012
PubMed
Publication types
Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
211
iCite
Relative citation ratio, by iCite
7.24
iCite
Revised in PubMed
2026-05-18
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Herreros MDM D
2Garcia-Arranz MM
3Guadalajara HH
4De-La-Quintana PP
5Garcia-Olmo DD
6FATT Collaborative GroupGroup

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdipocytesMajor topic
Fibrin Tissue AdhesiveMajor topic
Mesenchymal Stem Cell TransplantationMajor topic
Rectal FistulaMajor topic
Tissue AdhesivesMajor topic
Adult
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Male
Middle Aged
Single-Blind Method
Spain
Transplantation, Autologous
Treatment Outcome

Source PubMed

Download CSV of topics

Trials5

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00475410Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s DiseaseDerived from the trialYesClinicalTrials.gov
NCT01020825Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled TrialDerived from the trialYesClinicalTrials.gov
NCT04660903Treatment of Fistula in Ano With Autologous Fatty Tissue Cells TransplantationBackgroundClinicalTrials.gov
NCT04750499Treatment of Perianal Fistulas by Endorectal Advancement Flap Associated With Adipose Tissue InjectionBackgroundClinicalTrials.gov
NCT05201209LASER FiLaC™ (FISTULA LASER CLOSURE) : First-line Treatment of Complex Anal FistulasBackgroundClinicalTrials.gov

Download CSV of trials

Cited by127

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.

PMIDTitleJournalYearIn PapersSource
42332719Use of microfragmented autologous adipose tissue (LIPOGEMS®) as a sphincter-saving therapy for complex anal fistulas: a single-center retrospective study.BMC Surg2026https://conductscience.org/library/papers/42332719PubMed
42149263Efficacy and safety of freshly collected autologous adipose tissue for complex anal fistulas in non-IBD patients: a prospective cohort study.Tech Coloproctol2026https://conductscience.org/library/papers/42149263PubMed
41968436Effect of polydeoxyribonucleotide as a potential therapeutic agent to enhance the healing of Crohn's perianal fistula.Inflamm Bowel Dis2026https://conductscience.org/library/papers/41968436PubMed
41821809Current status and clinical applications of tissue engineering of the gastrointestinal tract: a systematized narrative review.Front Gastroenterol (Lausanne)2023https://conductscience.org/library/papers/41821809PubMed
41782164Repairing Peri-Anal Fistulas with regenerative cell therapeutics: study protocol for a double-blinded randomized controlled phase I-II trial from Denmark (REP-PAF).Trials2026https://conductscience.org/library/papers/41782164PubMed
41389226Research progress of stem cell transplantation in the treatment of anal fistula.Surg Today2026https://conductscience.org/library/papers/41389226PubMed
41357640Evidence outside the box: Minimally invasive treatment for anal fistula.World J Gastrointest Surg2025https://conductscience.org/library/papers/41357640PubMed
41023905Rapidly decellularized adipose tissue induces soft tissue vascularization in potential anatomical spaces.BMC Biotechnol2025https://conductscience.org/library/papers/41023905PubMed
40933558Adipose-derived stem cell therapies for complex anal fistula: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne)2025https://conductscience.org/library/papers/40933558PubMed
40442569Systematic review and network meta-analysis of cryptoglandular complex anal fistula treatment: evaluation of surgical strategies.Updates Surg2025https://conductscience.org/library/papers/40442569PubMed
40205247Systematic review and meta-analysis of the efficacy and safety of stem cell treatment of anal fistulas.Tech Coloproctol2025https://conductscience.org/library/papers/40205247PubMed
39944001Horizon scanning: new and future therapies in the management of inflammatory bowel disease.eGastroenterology2023https://conductscience.org/library/papers/39944001PubMed
39720270Long-term efficacy of mesenchymal stem cell treatment for complex perianal fistulas: A systematic review and meta-analysis.Cent Eur J Immunol2024https://conductscience.org/library/papers/39720270PubMed
39403342Refractory Crohn's Disease: Perspectives, Unmet Needs and Innovations.Clin Exp Gastroenterol2024https://conductscience.org/library/papers/39403342PubMed
38980511Efficacy of injection of autologous adipose tissue in the treatment of patients with complex and recurrent fistula-in-ano of cryptoglandular origin.Tech Coloproctol2024https://conductscience.org/library/papers/38980511PubMed
38682120Hyperbaric Oxygen Therapy for Refractory Perianal Crohn's Disease: A Case Report.Gastroenterol Hepatol (N Y)2024https://conductscience.org/library/papers/38682120PubMed
38550268Optimum management for complex anal fistula: A network meta-analysis of randomized controlled trials.Surg Open Sci2024https://conductscience.org/library/papers/38550268PubMed
37904247Efficacy and safety of allogeneic umbilical cord-derived mesenchymal stem cells for the treatment of complex perianal fistula in Crohn's disease: a pilot study.Stem Cell Res Ther2023https://conductscience.org/library/papers/37904247PubMed
37700821Up-to-date meta-analysis of long-term evaluations of mesenchymal stem cell therapy for complex perianal fistula.World J Stem Cells2023https://conductscience.org/library/papers/37700821PubMed
37485563The Impact of Cellular Therapies on Gastrointestinal Diseases: Applications and Challenges.Turk J Gastroenterol2023https://conductscience.org/library/papers/37485563PubMed

See all 127 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22706128

GET https://conductscience.org/api/papers/v1/22706128/cited_by?page=2